news Beautyberry leaf could be the secret to combatting MRSA infections 17 July 2020 | By Hannah Balfour (Drug Target Review) A compound extracted from the leaf of the American beautyberry re-sensitised methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics.
news Metal-containing compounds could lead to new antibacterials 2 March 2020 | By Hannah Balfour (Drug Target Review) International collaboration has shown that compounds with metals in them show antibacterial activity against MRSA, E. coli and A. baumannii.
news Making old antibiotics work better using r8 7 November 2018 | By Iqra Farooq (Drug Target Review) A team of researchers have developed a way that could enhance the effect of current antibiotics, using a small molecular attachment called r8...
news Immune system found to protect against MRSA infections 7 February 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus...
news Study reveals how MRSA infection compromises lymphatic function 18 January 2018 | By Drug Target Review MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
news New study reports cannabinoid effective against antibiotic-resistant MRSA 30 March 2017 | By Sarah Wills (Drug Target Review) Researchers have found that cannabinoid-based therapies have unique anti-bacterial properties that fight MSRA and other infectious bacteria.
article Theravance on Vibativ and fighting antimicrobial resistance 20 June 2016 | By Victoria White, Digital Content Producer We recently caught up with Frank Pasqualone of Theravance Biopharma to find out about the latest study results for the company's antibiotic, Vibativ...
news TXA709 treats MRSA infection and restores efficacy of cefdinir 14 June 2016 | By Victoria White, Digital Content Producer The combination of TXA709 with cefdinir, an antibiotic that has been on the market for almost two decades, successfully treated MRSA infection in animals...